Unlike systemic ALCL, BIA-ALCL tends to follow an indolent course; with an overall 5 year survival rate of 89-92%, compared to 37-49% and 70-93% in ALK− and ALK+ systemic ALCL, respectively [11,17,59]. Here, ALK is linked to anaplastic large cell lymphoma.